Recent News


July 27, 2020

Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav™ Oral Solution for Narcolepsy

DUBLIN, July 22, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution on July 21, 2020 for the treatment of cataplexy ...
July 06, 2020

AASM Patient Guides Available

The American Academy of Sleep Medicine has developed patient guides for several clinical practice guidelines. Patients can use these to help identify what questions to ask their physician and understand diagnosis and treatment options.
June 22, 2020

Insomnia Awareness Night - June 22, 2020

Insomnia affects millions of people in the United States. The AAHS, in conjunction with the AASM and SRS, seeks to raise awareness of insomnia through Insomnia Awareness Night on June 22, 2020.